Nanodisc Platform (ND)

The Nanodisc platform is a synthetic model membrane system consisting of a phospholipid bilayer disk encircled by two molecules of a membrane scaffold protein (MSP), typically derived from human apolipoprotein A-I (Sligar & Denisov, 2021). This technology provides a stable, detergent-free, and soluble environment that mimics the native lipid bilayer, making it an essential tool for studying the structure and function of membrane-bound proteins such as G protein-coupled receptors (GPCRs) and ion channels (Bayburt & Sligar, 2010). While not a biological target itself, the platform is utilized in drug discovery to facilitate the screening of small molecules and biologics against challenging membrane targets. Furthermore, Nanodiscs are being developed as therapeutic delivery vehicles, particularly for cancer vaccines and hydrophobic drugs, due to their ability to present antigens effectively and improve the pharmacokinetic profiles of encapsulated cargo (Kuai et al., 2017). In cardiovascular medicine, HDL-mimetic nanodiscs are investigated for their ability to promote reverse cholesterol transport and stabilize atherosclerotic plaques (Tardif et al., 2007). These synthetic assemblies allow for the precise control of lipid composition and disk size, which is critical for maintaining the native conformation of embedded proteins (Denisov & Sligar, 2016). Overall, the Nanodisc platform bridges the gap between membrane biology and drug development by providing a robust framework for both basic research and clinical applications.

Other names

Membrane Scaffold Protein NanodiscMSP NanodiscSynthetic Membrane DiskLipid NanodiscHDL-mimetic Nanodisc

Nanodiscs function as a stable, soluble phospholipid bilayer platform that mimics the native cellular membrane environment. They encapsulate membrane proteins or hydrophobic therapeutic agents, facilitating structural analysis, high-throughput screening, or targeted delivery to specific tissues (Sligar & Denisov, 2021). In cardiovascular applications, they act as high-density lipoprotein (HDL) mimetics that sequester excess cholesterol from peripheral tissues and transport it to the liver for excretion (Tardif et al., 2007).